Carmel, IN, United States of America

James H Anderson, Jr

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James H Anderson, Jr. Retrieved from https://idiyas.com/inventor/james-h-anderson-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 147(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of James H Anderson, Jr.

Introduction

James H Anderson, Jr. is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin formulations. His work has the potential to improve the management of diabetes through innovative drug delivery methods.

Latest Patents

Anderson holds a patent for "Insulin analog formulations." This invention discloses various parenteral pharmaceutical formulations that comprise a mixture of a monomeric insulin analog and insulin-NPH. The analog formulations provide a rapid onset and a prolonged duration of action, which can greatly benefit patients requiring insulin therapy.

Career Highlights

Anderson is associated with Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly has allowed him to work on groundbreaking research and development projects that aim to enhance patient care and treatment options.

Collaborations

Throughout his career, Anderson has collaborated with esteemed colleagues, including Michael R De Felippis and Bruce H Frank. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

James H Anderson, Jr. is a prominent figure in the field of pharmaceutical innovation, with a focus on insulin formulations that can improve the lives of many patients. His contributions to the industry exemplify the importance of research and development in advancing medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…